Bret Barnhizer and Dana Allen Elected to NanoLogix Board of Directors

SHARON, PA -- (MARKET WIRE) -- February 27, 2007 -- NanoLogix, Inc. (PINKSHEETS: NNLX) announces the election of Bret Barnhizer and Dana Allen to its Board of Directors. Mr. Barnhizer will serve as Director-At-Large with Mr. Allen serving as Vice President of Strategic Partnering. The addition of Mr. Barnhizer and Mr. Allen expands the number of directors on the NanoLogix board to five.

Bret Barnhizer

For more than 25 years, Bret Barnhizer has provided engineering, operations management, and project management services to Chevron, BP, Unocal, Occidental Petroleum, and others in the U.S., Europe, Africa, and Asia. Mr. Barnhizer has managed and been involved in projects of varied scope, ranging from 40 million to over 500 million dollars in value.

Dana Allen

Dana Allen has 26 years of business experience in numerous industries and sectors; Mr. Allen was the Founder, Chairman and CEO of Sequoia Data Corp. (1987-1996); Vice President then later Chairman, CEO and President of TMSSequoia (a public co.) (1996-1999) where he was granted 8 patents for various inventions; Co-Founder and Chairman of NewsMax (1998-2000), President of American Investigator Television (2000-2001). Mr. Allen is currently President of Sequoian Technologies, an invention creation and marketing firm whose primary business is to market patents by Mr. Allen and others in a broad range. The first patents to be filed relate to reducing emissions approximately 90% in 2-Stroke engines and a new 4 Stroke Engine Cycle method that will improve fuel economy.

"We are extremely pleased to welcome Bret and Dana to the NanoLogix Board of Directors," said CEO Mitchell Felder, M.D. "I anticipate that their individual professional experience, business acumen and personal integrity will enable them to contribute meaningfully to the further formation of our strategy and to serve NanoLogix shareholders well."

"I am excited to join the Nanologix team," said Director, Dana Allen. "It is the most technology rich company of its size I have ever seen. The Board is focusing on commercializing the company's valuable patents and technologies. We see the opportunity for these technologies having profound positive effects for the world in addition to their commercial value."

About NanoLogix, Inc.:

NanoLogix is an industry innovator in the research, development and commercialization of nano-biotechnologies, applications and processes. The Company owns or has the rights to 32 patented technologies. The Company is currently focused on the production of hydrogen from agricultural feedstock, industrial wastewater and municipal waste streams to create new sources of energy. NanoLogix is presently operating a hydrogen bioreactor at Welch's Food and has recently signed an agreement with the City of Erie Wastewater Treatment Plant for a prototype bioreactor installation. Additionally, NanoLogix develops and markets diagnostic test kits for use in early detection of infectious human diseases such as cancer, cystic fibrosis and AIDS, and owns a patent for the non-toxic induction of apoptosis ('cell suicide') for the treatment of cancer. For more information on the Company, visit http://www.nanologix.net.

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information: Contacts: Investor Relations Andrew Barwicki 516.662.9461 Website: www.nanologix.net